Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SAMe (S-adenosylmethionine) is the main methyl donor group in the cell. MAT (methionine adenosyltransferase) is the unique enzyme responsible for the synthesis of SAMe from methionine and ATP, and SAMe is the common point between the three principal metabolic pathways: polyamines, transmethylation and transsulfuration that converge into the methionine cycle. SAMe is now also considered a key regulator of metabolism, proliferation, differentiation, apoptosis and cell death. Recent results show a new signalling pathway implicated in the proliferation of the hepatocyte, where AMPK (AMP-activated protein kinase) and HuR, modulated by SAMe, take place in HGF (hepatocyte growth factor)-mediated cell growth. Abnormalities in methionine metabolism occur in several animal models of alcoholic liver injury, and it is also altered in patients with liver disease. Both high and low levels of SAMe predispose to liver injury. In this regard, knockout mouse models have been developed for the enzymes responsible for SAMe synthesis and catabolism, MAT1A and
GNMT
(
glycine N-methyltransferase
) respectively. These knockout mice develop steatosis and
HCC
(hepatocellular carcinoma), and both models closely replicate the pathologies of human disease, which makes them extremely useful to elucidate the mechanism underlying liver disease. These new findings open a wide range of possibilities to discover novel targets for clinical applications.
...
PMID:S-adenosylmethionine and proliferation: new pathways, new targets. 1879 49
Glycine N-methyltransferase
(
GNMT
) is a tumor suppressor for
HCC
. It is down-regulated in
HCC
, but the mechanism is not fully understood. MicroRNA-224 (miR-224) acts as an onco-miR in
HCC
. This study is the first to investigate miR-224 targeting the coding region of
GNMT
transcript. The
GNMT
-MT plasmid containing a miR-224 binding site silent mutation of the
GNMT
coding sequence can escape the suppression of miR-224 in HEK293T cells. Expression of both exogenous and endogenous
GNMT
was suppressed by miR-224, while miR-224 inhibitor enhanced
GNMT
expression. miR-224 counteracts the effects of
GNMT
on the reduction of cell proliferation and tumor growth. The levels of miR-224 and
GNMT
mRNA showed a significant inverse relationship in tumor specimens from
HCC
patients. Utilizing CCl4-treated hepatoma cells and mice as a cell damage of inflammatory or liver injury model, we observed that the decreased expression levels of
GNMT
were accompanied with the elevated expression levels of miR-224 in hepatoma cells and mouse liver. Finally, hepatic AAV-mediated
GNMT
also reduced CCl4-induced miR-224 expression and liver fibrosis. These results indicated that AAV-mediated
GNMT
has potential liver protection activity. miR-224 can target the
GNMT
mRNA coding sequence and plays an important role in
GNMT
suppression during liver tumorigenesis.
...
PMID:MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma. 3011 77
The methionine and folate cycles play a fundamental role in cell physiology and their alteration is involved in liver injury and hepatocarcinogenesis.
Glycine N-methyltransferase
is implicated in methyl group supply, DNA methylation, and nucleotide biosynthesis. It regulates the cellular S-adenosylmethionine/S-adenosylhomocysteine ratio and S-adenosylmethionine-dependent methyl transfer reactions.
Glycine N-methyltransferase
is absent in fast-growing hepatocellular carcinomas and present at a low level in slower growing
HCC
ones. The mechanism of tumor suppression by
glycine N-methyltransferase
is not completely known.
Glycine N-methyltransferase
inhibits hepatocellular carcinoma growth through interaction with Dep domain-containing mechanistic target of rapamycin (mTor)-interacting protein, a binding protein overexpressed in hepatocellular carcinoma. The interaction of the phosphatase and tensin homolog inhibitor, phosphatidylinositol 3,4,5-trisphosphate-dependent rac exchanger, with
glycine N-methyltransferase
enhances proteasomal degradation of this exchanger by the E3 ubiquitin ligase HectH.
Glycine N-methyltransferase
also regulates genes related to detoxification and antioxidation pathways. It supports pyrimidine and purine syntheses and minimizes uracil incorporation into DNA as consequence of folate depletion. However, recent evidence indicates that
glycine N-methyltransferase
targeted into nucleus still exerts strong anti-proliferative effects independent of its catalytic activity, while its restriction to cytoplasm prevents these effects. Our current knowledge suggest that
glycine N-methyltransferase
plays a fundamental, even if not yet completely known, role in cellular physiology and highlights the need to further investigate this role in normal and cancer cells.
...
PMID:Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury. 3017 91